Literature DB >> 60479

Effects of modification of intracellularcyclic AMP levels on the imediate hypersensitivity reaction in vivo.

D A Deporter, F Capasso, D A Willoughby.   

Abstract

Experiments were performed to study the effects of agents that elevate endogenous cyclic AMP levels on the progression of a reverse passive Arthus reaction in the pleural cavity of rats. Three hours after the onset of the reaction a marked reduction in histamine release was observed which correlated well with increases in cellular cyclic AMP concentration. The results at 6 hr suggested a relationship between cyclic AMP and leucocyte PGE, the latter being reduced dramatically both in the cells and in the fluid exudate by agents that elevate cyclic AMP. It was concluded that cyclic AMP may play an important regulatory role in vivo in the release of inflammatory mediators from leucocytes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60479      PMCID: PMC8335187          DOI: 10.1002/path.1711190304

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Cyclic adenosine 3', 5'-monophosphate and the mechanism of action of three common anti-inflammatory drugs.

Authors:  D A Deporter; C J Dunn; D A Willoughby
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

2.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

3.  New types of therapy for the arthropathies and inflammatory disease [proceedings].

Authors:  D A Willoughby; W G Spector; E C Huskisson; M Foldi; J Casley-Smith; C J Dunn
Journal:  Agents Actions       Date:  1978-01

4.  Inhibition by cholera toxin of rat polymorphonuclear leukocyte chemotaxis demonstrated in vitro and in vivo.

Authors:  M Roch-Arveiller; P Boquet; D Bradshaw; J P Giroud
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

5.  Cyclic adenosine 3',5'-monophosphate and leucocyte chemotaxis in vivo.

Authors:  D A Deporter
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.